Key result
This review provides a comprehensive update on implantable cardioverter defibrillator management, covering implantation procedures, follow-up care, complications, and future perspectives.
This review provides a comprehensive update on the management of patients with implantable cardioverter defibrillators, covering implantation, follow-up, complications, and future perspectives.
May guide current ICD follow-up and complication strategies; leaves open needs for prospective trials on future technologies.
Implantable cardioverter defibrillator (ICD) is the cornerstone of primary and secondary prevention of sudden cardiac death. In 35 years of technologic improvement and clinical trials, there has been a continuous increase in implantation rate. Purpose of this review is to point out and discuss every aspect related to actual ICD management, investigating implantation procedure and predischarge care, office and remote monitoring follow-up, diagnostic evaluations, management of patients with suspected therapies or malfunctions, heart failure, surgery, radiotherapy and endoscopic procedures. Also, ICD backface such as infections and other complications will be discussed. Finally, we will focus on interesting future perspectives for this setting of patients.
No takes yet. Share an insight, caveat, or question.
Malagù et al. (2016) conducted a review in Sudden cardiac death prevention. Implantable cardioverter defibrillator (ICD) management was evaluated. This review provides a comprehensive update on implantable cardioverter defibrillator management, covering implantation procedures, follow-up care, complications, and future perspectives.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: